Helminth therapy – local and systemic activity, on example of inflammatory bowel diseases and multiple sclerosis

Autoimmunological diseases are an increasing problem nowadays in societies. Due to complex etiology, effective therapy against immune disorders is still needed. A promising alternative for the current methods of treatment can be helminthic therapy. Series of tests on animal models as well as clinical studies indicates that parasitic infection can inhibit inflammation in inflammatory bowel diseases and multiple sclerosis. Effectiveness of therapy with helminths, mainly gut nematodes depends on the activity of many compounds released during infection. Despite hopeful results, mechanisms activated by nematodes aren’t explained yet, besides, therapeutically use of live parasites is controversial. Most of studies are focused on searching parasitic factors. The use of this compound in autoimmunological diseases could be an alternative for current medicaments. The aim of current study is summarizing and discussing helminth therapy of autoimmunological disorder on multiple sclerosis and inflammatory bowel diseases examples as well as using parasitic compounds as a potential pharmaceutical component.

• Publication year

  2019

• Venue

  Postȩpy higieny i medycyny doświadczalnej

• Publication date

  2019-12-02

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.5604/01.3001.0013.6092
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cytokines in inflammatory bowel disease

  2014cited by this paper
• Absence of a role for interleukin‐13 in inflammatory bowel disease

  2014cited by this paper
• Helminth/Parasite Treatment of Multiple Sclerosis

  2014cited by this paper
• Secretion of Protective Antigens by Tissue-Stage Nematode Larvae Revealed by Proteomic Analysis and Vaccination-Induced Sterile Immunity

  2013cited by this paper
• Colitis Promotes Adaptation of an Intestinal Nematode: A Heligmosomoides Polygyrus Mouse Model System

  2013cited by this paper
• Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial

  2013cited by this paper
• The critical importance of epigenetics in autoimmunity.

  2013cited by this paper
• Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease

  2013cited by this paper
• Heligmosomoides polygyrus antigens inhibit the intrinsic pathway of apoptosis by overexpression of survivin and Bcl-2 protein in CD4 T cells

  2013cited by this paper
• Effect of Hookworm Infection on Wheat Challenge in Celiac Disease – A Randomised Double-Blinded Placebo Controlled Trial

  2011cited by this paper
• Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14⁺ macrophages.

  2011cited by this paper
• Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis

  2011cited by this paper
• THE ROLE OF IL-13 AND NK T CELLS IN EXPERIMENTAL AND HUMAN ULCERATIVE COLITIS

  2008cited by this paper
• Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies.

  2007cited by this paper
• The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

  2006cited by this paper
• Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial.

  2005cited by this paper
• Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.

  2005cited by this paper
• Bodyguards and assassins: Bcl‐2 family proteins and apoptosis control in chronic lymphocytic leukaemia

  2005cited by this paper
• A proof of concept study establishing Necator americanus in Crohn’s patients and reservoir donors

  2005cited by this paper
• Vomiting in the recently anticoagulated patient

  2004cited by this paper
• Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease

  2003cited by this paper
• Molecular cloning of a protective antigen of schistosomes

  1987cited by this paper

• Gastrointestinal parasitosis diagnosed by colonoscopy as cause of weight loss in 46-year-old woman with three negative stool tests for presence of parasites

  2023cites this paper
• Both the microbiome and the macrobiome can influence immune responsiveness in psoriasis

  2021cites this paper